跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aficamten
首页
药物
Aficamten
Investigational
Small Molecule
Aficamten
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
18
H
19
N
5
O
2
CAS 编号
2364554-48-1
UNII ID
B1I77MH6K1
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
EP 4370116 B1
申请人: CYTOKINETICS INC
优先权: 2021
EP
US
WO
7 件公开
PROCESS FOR PREPARING AFICAMTEN
EP 4380932 C0
申请人: CYTOKINETICS INC
优先权: 2021
EP
US
WO
6 件公开
CO-CRYSTAL OF AFICAMTEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF
US 20250382286 A1
申请人: CRYSTAL PHARMACEUTICAL SUZHOU CO LTD
优先权: 2023
CN
US
2 件公开
METHODS FOR TREATING HEART DISEASES
US 20250295639 A1
申请人: CYTOKINETICS INC
优先权: 2024
US
WO
2 件公开
NEW PROCESS FOR PREPARATION OF AFICAMTEN
US 20250034095 A1
申请人: ZYDUS LIFESCIENCES LTD
优先权: 2023
US
"AMORPHOUS SOLID DISPERSION OF AFICAMTEN AND PROCESS FOR THEIR PREPARATION"
WO 2025220034 A1
申请人: DR REDDY’S LABORATORIES LTD
优先权: 2024
WO
USE IN PREPARATION OF DRUG FOR TREATING HYPERTROPHIC CARDIOMYOPATHY
WO 2026130464 A1
申请人: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
优先权: 2024
WO
USE FOR PREPARING DRUG FOR TREATING NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
WO 2026153470 A1
申请人: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
优先权: 2025
WO
Preparation method of Aficamten
CN 120535511 A
申请人: SHANGHAI SCIENPHARM BIOTECHNOLOGY CO LTD
优先权: 2025
CN
CN 120699008 A
申请人: SHANGHAI SCIENPHARM BIOTECHNOLOGY CO LTD
优先权: 2025
CN
药物
反馈